Esbriet (pirfenidone) can be used as a long-term therapy in idiopathic pulmonary fibrosis (IPF) patients with more severe loss of lung function, according to results presented at the American College of Chest Physicians (CHEST 2016), held in Los Angeles from Oct. 22–26. The findings were described in the oral presentation, “…
In this University of Exeter video, Dr. Chris Scotton talks about his research in idiopathic pulmonary fibrosis in order to better understand the development of the disease, and to try to develop new model systems for drug testing. Discover why pulmonary fibrosis is so…
Results from two Phase 3 studies, known as the INPULSIS trials, further confirmed the efficacy of Ofev (nintedanib) to treat idiopathic pulmonary fibrosis (IPF) regardless of disease severity. The results, from post-hoc pooled analyses of the trials, were recently presented at the CHEST 2016 Annual Meeting, running in Los Angeles through Wednesday, Oct. 26.
In this film produced and shared by Elisabeth Leveque-Mumford in July 2011, we meet Hélène Campbell a young woman who had just recently been diagnosed with advanced idiopathic pulmonary fibrosis (IPF). Discover six less-common symptoms of idiopathic pulmonary fibrosis here. Hélène talks about how IPF has impacted her life,…
I recently had a victory in a fight for oxygen, and wanted to share what I learned through the process. I had to fight for oxygen … pretty basic need, right? Like many of you, I’m on supplemental oxygen 24/7. It’s been two years, and it has been a fight…
According to the Mayo Clinic, though no current cure for pulmonary fibrosis exists yet, medications and other treatment options can help improve a patient’s quality of life. As the disease evolves, several complications may arise. Here is a list of six possible pulmonary fibrosis complications: 1. High blood pressure in the lungs: Unlike normal high…
Mesenchymal stem cells show considerable potential as a means of treating idiopathic pulmonary fibrosis (IPF), but numerous issues need to be resolved before a stem cell approach might benefit patients. The study, “Mesenchymal stem cells in the treatment of chronic lung disease,” published in the journal Respirology, also underscored…
In this video from Boehringer Ingelheim Idiopathic Pulmonary Fibrosis, learn more about the reality of living with IPF and how every single breath counts for the patients living with this disease. Discover why pulmonary fibrosis is so difficult to diagnose and treat.
Inspired by an article written by a wonderful writer, and talented individual who I’m lucky enough to call a friend, I have decided use this post and take a look back at what my life was like a year ago, before IPF. This feels significant in a few different ways,…
‘Exhale, Mindfully Manage Your IPF’ is a new initiative co-sponsored by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), the Pulmonary Fibrosis Foundation, and the international biotechnology firm Genentech. The program’s aim is to help people living with idiopathic pulmonary fibrosis (IPF), and encourage…
Get regular updates to your inbox.
